drugset / Trial / NCT04503863

An Additional Study of NPC-22 in Healthy Adult Males

NCT04503863 ↗

Phase 1 Completed 32 enrolled Nobelpharma
RandomizedSequentialQuadruple-blindBasic science

Summary

The purpose of this study is to examine the safety and pharmacokinetics of high dose NPC-22 administration in healthy adult males. The effect of administration routes for pharmacokinetics will be examined in advance.

Timeline

Start
2020-07-20
Primary completion
2020-11-06
Completion
2021-12-28

Drugs

EvaluationDrugModalityDoseRoute
Subject NPC-22 Unknown — —

Indications

No indication recorded.